supported by grants from the National Natural Science Foundation of China(81971641,82071200,82272039,and 82021002);the STI2030-Major Project(2022ZD0211600);the Clinical Research Plan of Shanghai Hospital Development Center(SHDC2020CR1038B,SHDC2020CR4007);the National Key R&D Program of China(2022YFC2009902,2022YFC2009900);Medical Innovation Research Project of Shanghai Science and Technology Commission(21Y11903300).
Background Gaining more information about the reciprocal associations between different biomarkers within the ATN(Amyloid/Tau/Neurodegeneration)framework across the Alzheimer’s disease(AD)spectrum is clinically relev...
The author's research is funded by the Canadian Consortium on Neurodegeneration in Aging,the Canadian Institutes for Health Research,and The Weston Brain Institute.
Background:The NIA-AA research framework proposes a biological definition of Alzheimer’s disease,where asymptomatic persons with amyloid deposition would be considered as having this disease prior to symptoms.Discuss...